Full Committee Hearing FDA User Fee Agreements: Improving Medical Product Regulation and Innovation for Patients Part I

Date: Tuesday, March 21, 2017 Time: 10:00 AM Location: 430 Dirksen Senate Office Building

Open in New Window

Witnesses

  1. Janet Woodcock, MD
    Director
    Center for Drug Evaluation and Research, Food and Drug Administration
    Silver Spring, MD
  2. Peter Marks, Ph.D
    Director
    Center for Biologics Evaluation and Research, Food and Drug Administration
    Silver Spring, MD
  3. Jeffrey E. Shuren, MD, JD
    Director
    Center for Devices and Radiological Health, Food and Drug Administration
    Silver Spring, MD

Transcripts

Those in need of accommodations, including closed captioning for webcast hearings, should contact the Committee at 202-224-5375 or accessibility@help.senate.gov. So as to best enable staff to make arrangements, please call or email at least 3 business days in advance of the hearing.